Chordia Therapeutics Inc. carries a market capitalization of 6.09B, placing it among publicly traded companies globally.
| Market Cap | 6.09B |
| Enterprise Value | N/A |
Chordia Therapeutics Inc.'s stock has declined approximately -60.09852% over the past 52 weeks. The 50-day moving average sits at 107.74, while the 200-day moving average is 117.47.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60.09852% |
| 50-Day Moving Average | 107.74 |
| 200-Day Moving Average | 117.47 |
| Average Volume (20 Days) | N/A |